Table 4.
BP uncontrolled N=673 (%) |
BP controlled N=1381(%) |
Unadjusted OR (95% CI) |
Adjusted OR* (95%CI) |
|
---|---|---|---|---|
Gender | ||||
Male | 97.4 | 97.4 | Ref | Ref |
Female | 2.6 | 2.6 | 0.97 (0.54, 1.74) | 0.87 (0.47, 1.62) |
Age | ||||
<65 | 53.8 | 49.1 | Ref | Ref |
65–74 | 21.6 | 22.0 | 1.12 (0.88, 1.42) | 1.25 (0.96, 1.63) |
75+ | 24.6 | 28.9 | 1.28 (1.03, 1.61) | 1.23 (0.95, 1.59) |
Race* | ||||
White | 59.8 | 69.1 | Ref | Ref |
Black | 30.0 | 24.2 | 0.69 (0.55, 0.86) | 0.84 (0.66, 1.06) |
Other | 10.0 | 6.8 | 0.59 (0.41, 0.84) | 0.63 (0.44, 0.91) |
N Co-morbidities at admission (mean± SD) | 3.4 ± 2.0 | 3.5 ± 2.0 | 1.03 (0.98, 1.08) | 1.06 (0.96, 1.17) |
Co-morbidities | ||||
Cerebrovascular disease | 24.6 | 28.0 | 1.20 (0.97, 1.49) | 1.16 (0.89, 1.50) |
CVD | 32.6 | 36.5 | 1.19 (0.98,1.45) | 1.02 (0.76, 1.36) |
Diabetes | 46.2 | 40.2 | 0.78 (0.65, 0.94) | 0.81 (0.64, 1.03) |
Hypertension | 87.0 | 77.3 | 0.51 (0.39, 0.66) | 0.52 (0.38, 0.71) |
Hyperlipidemia | 50.8 | 54.2 | 1.15 (0.95, 1.38) | 1.08 (0.86, 1.37) |
Systolic BP at Discharge mmHg (mean± SD) | 141 ± 22 | 133 ± 19 | 0.98 (0.98, 0.99) | 0.99 (0.98, 0.99) |
Diastolic BP at Discharge mmHg (mean± SD) | 79 ±14 | 75 ± 12 | 0.97 (0.97, 0.98) | 0.99 (0.98,1.00) |
N Visits Post Discharge (mean± SD) | 5.8 ± 4.9 | 6.2 ±4.8 | 1.02 (1.00, 1.04) | 1.02 (0.99, 1.04) |
Antihypertensives at DC | ||||
Thiazide + ACE/ ARB | 18.2 | 15.9 | 0.85 (0.66, 1.08) | 1.20 (0.88, 1.62) |
Thiazide | 6.4 | 6.7 | 1.06 (0.72, 1.54) | 1.24 (0.80, 1.91) |
ACE/ARB | 40.2 | 39.8 | 0.98 (0.81, 1.19) | 1.09 (0.86, 1.39) |
Beta Blockers | 52.0 | 47.6 | 0.84 (0.70, 1.01) | 0.90 (0.72, 1.11) |
CCB | 31.6 | 25.3 | 0.73 (0.60, 0.90) | 0.90 (0.72, 1.13) |
All other classes | 33.6 | 31.0 | 0.89 (0.73, 1.08) | 0.89 (0.71, 1.11) |
One hundred thirty-nine patients were missing race information-- BP uncontrolled N= 45 (6.7%) and BP controlled N=94 (6.8%). The resulting adjusted logistic model had 1915 patients and included the variables gender, age, race, history of cardiovascular disease, cerebrovascular disease, Diabetes, hypertension, hyperlipidemia, number of co-morbidities at admission, systolic and diastolic BP at discharge, number of visits since hospital discharge, class of antihypertensive drugs prescribed at discharge. Facility was a random effect (N=125)